NCT04519905View on ClinicalTrials.gov

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

NARecruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
Esophageal Squamous Cell CarcinomaChemoradiotherapySurvival
Interventions
DRUG

Paclitaxel plus carboplatin

Paclitaxel （45mg/m2) plus carboplatin (AUC=2); five cycles; qw

RADIATION

radiotherapy

Different radiotherapy dose in different groups.

Trial Locations (3)

200000

RECRUITING

Huadong Hospital, Shanghai

200032

RECRUITING

Fudan Universtiy Shanghai Cancer Center, Shanghai

Unknown

RECRUITING

Jiangsu Cancer Hospital, Nanjing

All Listed Sponsors
collaborator

Huadong Hospital

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

Gansu Cancer Hospital

OTHER

collaborator

The First Affiliated Hospital of Xiamen University

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Taihe Hospital

OTHER

collaborator

Wuxi No. 4 People's Hospital

OTHER

collaborator

Ningbo No.2 Hospital

OTHER

lead

Fudan University

OTHER